Hi guys
Today both Luxchem & Hartalega released their great results this afternoon
Let's see
HARTALEGA
SUMMARY OF KEY FINANCIAL INFORMATION
|
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
|
CURRENT YEAR QUARTER
|
PRECEDING YEAR
CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR
CORRESPONDING PERIOD |
||
|
30 Sep 2020
|
30 Sep 2019
|
30 Sep 2020
|
30 Sep 2019
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
1,346,016
|
709,424
|
2,266,103
|
1,349,525
|
| 2 | Profit/(loss) before tax |
682,961
|
137,327
|
955,780
|
258,981
|
| 3 | Profit/(loss) for the period |
549,698
|
104,206
|
770,758
|
198,460
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
544,958
|
103,867
|
764,677
|
197,930
|
| 5 | Basic earnings/(loss) per share (Subunit) |
15.95
|
3.09
|
22.38
|
5.90
|
| 6 | Proposed/Declared dividend per share (Subunit) |
3.85
|
1.80
|
5.95
|
3.70
|
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 | Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.9900
|
0.7500
|
||
15.95 sen
Annualized 15.95 x 4 = 63.8 sen
If we assign P/E 30
Then 63.8 x 30 = Rm19.14
At current closing price Rm18.36 Hartalega upside is only 78 sen or 4% more to reach full value
Luxchem
SUMMARY OF KEY FINANCIAL INFORMATION
|
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
|
CURRENT YEAR QUARTER
|
PRECEDING YEAR
CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR
CORRESPONDING PERIOD |
||
|
30 Sep 2020
|
30 Sep 2019
|
30 Sep 2020
|
30 Sep 2019
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
191,260
|
187,488
|
506,033
|
578,325
|
| 2 | Profit/(loss) before tax |
18,847
|
11,352
|
42,259
|
37,365
|
| 3 | Profit/(loss) for the period |
14,169
|
8,243
|
30,792
|
27,538
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
14,204
|
8,583
|
31,758
|
28,076
|
| 5 | Basic earnings/(loss) per share (Subunit) |
1.59
|
0.96
|
3.55
|
3.20
|
| 6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
0.00
|
1.00
|
1.00
|
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 | Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.3600
|
0.330
|
||
1.59 sen
Annualized 1.59 x 4 = 6.36 sen
If P/E 30 then 6.36 x 30 = Rm1.90
Currect price 89.5 sen
So Rm1.05 or 117% more to reach Rm1.90
From these figures we SEE that Hartalega is almost fully valued while Luxchem still undervalue
And do you know that Topglove & Hartalega are Top 2 Biggest Customers of Luxchem Nitrile Glove Chemicals?
Warm regards
Calvin Tan Research
Singapore
Disclaimer
All information provided here should be treated for informational purposes only. It is solely reflecting author's personal views and the author should not be held liable for any actions taken in reliance on information contained herein.
OKOK
SEE HOW PEOPLE DON'T WANT TO ASSIGN P/E TO LUXCHEM & GLOVES NOW?
NO WONDER AFTER CAREPLUS GOOD RESULT OUT PRICES STILL DID NOT MOVE MUCH
HMMM?
ARE ALL GLOVES NOW OVERVALUED?
THEN HOW NOW?
YESSSS!!!
GO BUY JTIASA!!!
JTIASA IF IMPAIRMENTS NOT INCLUDED HAS A P/E OF LESS THAN 3JAYA TIASA = GIANT TREASURE
https://klse.i3investor.com/blogs/www.eaglevisioninvest.com/2020-10-27-story-h1535481759-LUXCHEM_RESULT_VERSUS_HARTALEGA_RESULT_COMPARE_CONTRAST_Calvin_Tan_Rese.jsp
